Get startedLog in
    Picture of Intra-Cellular Therapies logo

    ITCI — Intra-Cellular Therapies News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Intra-Cellular Therapies Reports First Quarter 2023 Financial Results

    Picture of Intra-Cellular Therapies logoIntra-Cellular Therapies
    04/05/2023 12:46
    May 4 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * INTRA-CELLULAR THERAPIES INC - CAPLYTA Q1 2023 NET PRODUCT
SALES
WERE $94.7 MILLION, COMPARED TO $34.8 MILLION FOR SAME PERIOD IN
2022
    * INTRA-CELLULAR THERAPIES INC - REITERATING CAPLYTA 2023
NET
PRODUCT SALES GUIDANCE OF $430 TO $455 MILLION
    * INTRA-CELLULAR THERAPIES INC- QTRLY LOSS PER SHARE $0.46

Source text for Eikon:  ID:nGNX2FqYL0 
Further company coverage:  ITCI.O

    Recent news on Intra-Cellular Therapies

    See all news